Uncategorized
Ocular Therapeutix reports $7.6 million in first quarter net loss
Ocular Therapeutix reported a net loss of approximately $7.6 million, or $0.35 per share, in the first quarter 2015 compared with a loss of $7 million, or $2.45 per share, in the first quarter of the previous year, according to a press release.Total revenue was $0.4 million compared with approximately $0.03 million in the first quarter 2014.